Chinese Novel Drug Developer Hinova Pharma Nets $40M In Series B Round
July 30, 2019 — 10:49 CST
This Data Is Locked!
This area is available only to Subscribers.
Hinova Pharma, a novel drug developer based in southwestern China’s Chengdu city, announced on Monday the completion of a US$40 million series B round of... [DATA LOCKED]
UNLOCK DATA
Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals
